All Type of News
FTC carries out change of braille indication from discretion to obligation
Braille transcription, which was regulated as a discretion, will be obligated.
The Fair Trade Commission(FTC) recently announced to prepared the ‘Recommendation for Improvement of Drug Indication’ with the Ministry o...
Which pharmaceutical companies made the largest collective sales?
On the 3rd quarter of this year, KOSDAQ pharmaceutical companies had a much higher increase rate of sales than the one of KOSPI pharmaceutical companies.
Yakup Shinmoon(www.yakup.com) analyzed sales that 34 KOSPI(Jei...
Layla’s use patent ruled nullified
The Supreme Court ruled to nullify the use patent of Layla(PMG Pharm), a natural drug, as of 23 November.
As PMG Pharm was dismissed at the request suit for injection against infringement on the use patent against fi...
CrystalGenomics acquires Japanese patent of Acelex composition
CrystalGenomics(CEO Joong-Myung Cho) announced the company acquired a Japanese patent of ‘Acelex’ composition on the 24th of November.
“Acquisition of the patent extended the Acelex’s composition patent term to 2035....
“Drugs with partially matched therapeutic category should not mention it”
The Ministry of Food and Drug Safety(MFDS) requested pharmaceutical companies not to mention efficacy on containers and packages if it does not match with the therapeutic category.
The MFDS(Minister Young-Jin Ryu) se...
Which listed company did record largest net profits?
By the 3rd quarter of this year, the KOSDAQ listed pharmaceutical companies’ collective net profits were 6 times larger than the one of the KOSPI market. In the net profit/sales rate, KOSDAQ listed pharmaceutical comp...
Sanofi, Huons Genexine with extended innovative pharmaceutical company certificate by 2020
Sanofi Aventis Korea, Genexine and Huons, the 3 companies’ innovative pharmaceutical company certificate will be extended to 2020. SK Chemicals, which recently had a corporate spin-off, was approved with the certifica...
Green Cross Labcell acquires U.S. patent of cell therapy mass production
Green Cross Labcell acquired a U.S. patent about mass production of cell therapy.
Green Cross Labcell(CEO Dae-Woo Park) announced on the 23rd that the company acquired a patent about culture method of natural killer ...
Pharma S decided to turn to accept returned medicines with no record
The issue of the pharmaceutical company S which sent back returned medicines with no shipping record has recently been addressed.
According to the distribution industry on the 24th, since the pharmaceutical company S...
Vemlidy and Besivo enters Severance Hospital at the same time
‘Vemlidy,’ a Gilead Sciences/Yuhan Corporation’s chronic hepatitis B treatment whose health insurance benefits have been applied from 1 November, and Ildong Pharmaceutical’s ‘Besivo’ entered in Severance Hospital.
Se...
